GlassScriptPhysician profile
Peggy Moore Gardner
NPI 1427463082
$3,031.20
in general payments reported to CMS, 2019-2025
23 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $750 · 2022: $698 · 2023: $370 · 2024: $786 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.64 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.17 | 2021-2024 | Jardiance |
| Glaxosmithkline, LLC. | $398.04 | 2021-2023 | |
| Novo Nordisk INC | $378.34 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $276.24 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $172.12 | 2021-2022 | |
| Hydrocision, INC. | $127.11 | 2024 | Tenjet |
| Amgen INC. | $118.51 | 2023 | Evenity |
| Althera Pharmaceuticals LLC | $105.00 | 2022 | |
| Edwards Lifesciences Corporation | $94.86 | 2024 | |
| Boston Scientific Corporation | $91.91 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.44 | 2025 | Xifaxan |
| Abbott Laboratories | $48.35 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.25 | 2024-2025 | Caplyta |
| Astellas Pharma US INC | $28.17 | 2024 | Veozah |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $26.70 | 2025 | Rexulti |
| Alexion Pharmaceuticals, INC. | $24.98 | 2021 | |
| Exact Sciences Corporation | $24.90 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $18.61 | 2023 | Gemtesa |
| Inogen, INC. | $15.00 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Biohaven Pharmaceuticals, INC. | $14.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.73 | 2021 | |
| Genentech USA, INC. | $10.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Moore Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.